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Aim To establish indirect reference intervals from patient 
results obtained during routine laboratory work as an alter-
native to laborious and expensive producing of their own 
reference range values according to international instruc-
tions.
Methods All results for thyrotropin (TSH) and free thyrox-
ine (T4) that were stored in our laboratory information sys-
tem between 2004 and 2008 were included in this study. 
After a logarithmic transformation of the raw data, outliers 
were excluded. Non-parametric reference intervals were 
estimated statistically after visual observation of the distri-
bution using stem-and-leaf plots and histograms. A stan-
dard normal deviation test was performed to test the sig-
nificance of differences between sub-groups.
Results There was no significant difference in serum TSH 
or free T4 concentrations between male and female partic-
ipants. Because no differences were found within the time 
span of the study, combined reference intervals were cal-
culated. Indirect reference values were 0.43-3.93 mU/L for 
TSH and 11.98-21.33 pmol/L for free T4.
Conclusion Using patient laboratory data values is a rela-
tively easy and cheap method of establishing laboratory-
specific reference values if skewness and kurtosis of the 
distribution are not too large.
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Reference values are medical decision-making tools that 
are provided by a clinical laboratory to aid the physician in 
differentiating a diseased patient from a healthy individu-
al. Establishing correct reference values and intervals is an 
important task for a clinical laboratory. However, a major 
problem that the laboratory faces is obtaining a sufficient 
number of specimens from healthy individuals representa-
tive of the population that the laboratory serves.
The complexity of establishing reference values and the 
cost and labor are additional difficulties. It has been con-
cluded by most of the European learned societies on clini-
cal chemistry that each clinical laboratory should produce 
its own reference values (1). However, very few laboratories 
actually do so. To make things easier, the International Fed-
eration of Clinical Chemistry (IFCC) published recommen-
dations for the transferability of the reference values from 
one institute to another, but even in this case, the labora-
tories involved should obtain comparable results and this 
can only be achieved by conducting long-term inter-labo-
ratory studies of the analytical methods in use, in terms of 
precision and accuracy (2,3). It may well be true that the 
best reference values for an individual are so-called “sub-
ject-based reference values,” derived from their own prior 
data, but again, such data are not often available.
Additionally, the IFCC definition of healthy ambulatory in-
dividuals may not be optimal references for hospitalized 
patients, because of differences in physical activity, diet, 
level of stress, diurnal rhythms, or other factors related to 
hospital stay. From this point of view, a hospitalized pa-
tient, not affected by the disease in question, but subject 
to the same conditions would be a better reference for a 
patient having a certain disease (4).
For all these reasons, some scientists working in the area 
have investigated the possibility of establishing reference 
values from large collections of laboratory data, using so-
phisticated laboratory information systems and statistical 
programs (5). The major advantage of using such an ap-
proach is that it saves a significant amount of money and 
work by using data that already exist.
Because subclinical thyroid dysfunction has few or no de-
finitive clinical signs or symptoms, it is essentially a labora-
tory diagnosis. Thus, the standardization of normal refer-
ence ranges of thyroid function tests is as important as the 
sensitivity of the tests and appropriate quality control pro-
cedures (6). This study was designed to estimate indirect 
reference values for two important thyroid function tests: 
thyrotropin (TSH) and free thyroxine (T4), using data stored 
in our laboratory information system from 2004 to 2008.
MeThodS
Patients
The results of TSH and free T4 from all the hospitals and 
health centers associated with Acibadem Health Group 
were included in the study. All diagnostic data have been 
stored in our laboratory information system (Tenay, Istan-
bul, Turkey) since 2004. Among them, the data from all 
patients above the age of 20 were selected to get adult 
thyroid hormone concentrations. Thyroid patients were 
not excluded from the study because they were expect-
ed to have very high or low thyroid function test results 
and would possibly be excluded while detecting the out-
liers. Only the first result for each patient was included. 
Quality control results and extreme values, such as those 
>200 or <0.005 mU/L for TSH and >100 pmol/L for free 
T4, were excluded from the study without any statistical 
analysis, because these values represent the detection lim-
its of the respective methods. All measurements were per-
formed using Elecsys 2010 analyzers (Roche Diagnostics, 
Mannheim, Germany) at all locations. Two levels of internal 
quality control were conducted daily and the tests were 
covered by an external quality assessment scheme (DGKL, 
Bonn, Germany); the laboratories included in the study had 
also been accredited by Deutsche Akkreditierungsstelle 
Chemie GmbH (http://www.dach-gmbh.de/), according 
to ISO 15189 standards, since 2005.
estimation of reference intervals
All data were analyzed by SPSS, version 11.5 for Windows 
(SPSS Inc., Chicago, IL, USA). Values were sorted in ascend-
ing order and, because the raw values showed a skewed 
curve with a long tail toward higher TSH values, they were 
first treated by log transformation of the original TSH val-
ues. The same treatment was applied for free T4 values as 
well. Histograms were visually inspected again because 
it was not likely to get a normal distribution even after 
transformation if skewness and kurtosis of the distribu-
tion were too large (by visual inspection). Outliers were 
identified and omitted using stem-and-leaf and box plots 
in SPSS statistical software. The software identifies outli-
ers first by computing the interquartile range (IQR) be-
tween the lower and upper quartiles of the distribution 
and then by determining the data lying outside 3 IQRs 
from the upper or lower edge of the box. The pro-
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cedure was repeated until no extremes were left. Then, 
the values were converted back to normal values by an 
anti-logarithmic procedure and extremes were again ex-
cluded.
For both analytes, a non-parametric method was applied 
to estimate the indirect reference intervals. The rank num-
bers of the 2.5th and 97.5th percentiles were computed as 
0.025(n + 1) and 0.975(n + 1), respectively. The reference 
intervals were then also estimated for men and women 
separately. The 90% confidence intervals for lower and up-
per limits were calculated according to the recommenda-
tions of the IFCC.
The standard normal deviation test (Z-test) was performed 
to reveal the significance of differences between the sub-
groups (eg, between years 2004-2005, 2005-2006, etc., and 
sex) according to the formula below (7):
where x1 and x2 are the calculated means of the two sub-
groups, s1
2 and s2
2 are the variances, and n1 and n2 are the 
number of patients in each group. The calculated z value is 
to be compared with a “critical” z value (7):
If the calculated z was greater than the critical z, then the 
means of the groups were considered to be different from 
each other. The critical value is a threshold value in which 
z corresponds to a sample size of n = 120 from each sub-
group. Value of z = 3 is used to represent a difference be-
tween subgroups just large enough to justify separate 
ranges (8).
ReSulTS
The shapes of the distributions of both analytes were 
positively skewed, which means that the mean of the dis-
tribution was at the right of the median. The total num-
ber of patients included in the study was 73 465 for TSH 
and 73 387 for free T4 at first, and then 18.1% of TSH and 
7.7% of free T4 results were excluded either because they 
lied outside the detection limit of the methodology or 
were detected as outliers after statistical treatment (Table 
1). The indirect reference limits and 90% confidence in-
tervals for TSH and free T4 were determined separately 
for each year between 2004 and 2008 and by sex (Table 
2 and Table 3). For two subclasses (men and women), the 
statistical significance of the difference between subclass 
means was tested by the standard normal deviation test 
(z-test). No difference was found between serum TSH and 
free T4 concentrations in male vs female participants (Ta-
ble 4). Thus, both sexes were combined for further calcu-
lations. The standard normal deviation test was also ap-
plied to see whether any significant difference occurred 
between consecutive years; no difference was found 
(Table 5). Finally, reference and confidence intervals for 
TSH (n = 55 318; 21.3% male, 78.7% female) and free T4 
(n = 62 713; 21.4% male, 78.6% female) were calculated 
from patient data (indirect method) and compared with 
TAble 1. The number of patients included in study and the numbers and percentages of excluded patients, detected as outliers 
calculated for each test and year*
No. (%) of patients
Analyte and year n odl log. trans. anti-log. trans. total
Thyrotropin:
2004   5581 165 (3.0)  572 (10.2) 283 (5.1) 1020 (18.3)
2005 13 912 340 (2.4) 1722 (12.4) 932 (6.7) 2994 (21.5)
2006 16 004 472 (3.0) 1607 (10.0) 762 (4.8) 2841 (17.8)
2007 19 617 770 (3.9) 1975 (10.1) 688 (3.5) 3433 (17.5)
2008 18 351 719 (3.9) 1610 (8.8) 649 (3.5) 2978 (16.2)
Free thyroxine:
2004   5578   3 (ND)  327 (5.9) 115 (2.1)  445 (8.0)
2005 13 892  12 (ND)  776 (5.6) 523 (3.8) 1311 (9.4)
2006 15 973  15 (ND)  787 (4.9) 455 (2.8) 1257 (7.9)
2007 19 604   5 (ND)  825 (4.2) 630(3.2) 1460 (7.4)
2008 18 340  12 (ND)  729 (4.0) 504 (2.7) 1245 (6.7)
*Abbreviations: odl – outside detection limit; log. trans. – after logarithmic transformation; anti-log. trans. – after back transformation; Nd – not 
done.
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transferred data, according to IFCC recommendations, 
which we currently use in our laboratory (direct method) 
and the manufacturer’s recommended reference inter-
vals (Table 6).
dISCuSSIoN
We established indirect reference intervals for TSH and free 
T4, using data stored in our laboratory information system. 
TAble 2. Indirect reference limits and confidence intervals for free thyroxine from the patient data according to years
Reference limit (90% confidence interval)
Year/sex n Mean ± standard deviation lower upper
2004:   5130 16.30 ± 2.42 11.9 (10.83-13.10) 21.6 (19.66-23.74)
male   1176 17.06 ± 2.45 12.5 (10.23-15.28) 22.21(18.17-27.14)
female   3954 16.16 ± 2.30 11.9 (10.74-13.19) 21.12 (19.10-23.41)
2005: 12 593 16.50 ± 2.41 12.10 (11.39-12.85) 21.62 (20.36-22.96)
mal   2860 17.29 ± 2.41 12.92 (11.38-14.67) 22.47 (19.80-25.51)
female   9733 16.24 ± 2.32 12.01 (11.27-12.83) 21.22 (19.87-22.67)
2006: 14 731 15.85 ± 2.22 11.78 (11.19-12.40) 20.63 (19.60-21.72)
male   3289 16.60 ± 2.26 12.52 (11.21-13.99) 21.54 (19.28-24.06)
female 11 442 15.63 ± 2.16 11.66 (11.07-12.34) 20.25 (19.13-21.43)
2007: 18 149 16.38 ± 2.31 12.06 (11.49-12.65) 21.27 (20.27-22.32)
male   4095 17.08 ± 2.36 12.66 (11.42-14.04) 22.16 (19.98-24.58)
female 14 054 16.19 ± 2.26 11.97 (11.35-12.63) 21.04 (19.94-22.20)
2008: 17 107 16.50 ± 2.30 12.31 (11.72-12.93) 21.45 (20.42-22.54)
male   4021 17.17 ± 2.31 12.89 (11.64-14.28) 22.18 (20.02-24.57)
female 13 086 16.29 ± 2.25 12.16 (11.51-12.85) 21.13 (19.99-22.33)
TAble 3. Indirect reference limits and confidence intervals for thyrotropin from the patient data according to years
Reference limit (90% confidence interval)
Year/sex n Mean ± standard deviation lower upper
2004:   4561 1.75 ± 0.98 0.38 (0.36-0.39) 4.00 (3.84-4.16)
male   1028 1.64 ± 0.90 0.40 (0.35-0.41) 3.69 (3.42-3.99)
female   3472 1.81 ± 1.00 0.38 (0.37-0.40) 4.11 (3.92-4.31)
2005: 10 918 1.84 ± 0.97 0.45 (0.44-0.46) 4.07 (3.97-4.18)
male   2468 1.70 ± 0.88 0.42 (0.40-0.44) 3.76 (3.57-3.95)
female   8475 1.90 ± 1.01 0.45 (0.44-0.47) 4.21 (4.08-4.34)
2006: 13 163 1.89 ± 1.01 0.43 (0.42-0.44) 4.24 (4.14-4.34)
male   2963 1.79 ± 0.93 0.46 (0.44-0.48) 3.94 (3.76-4.14)
female 10 212 1.93 ± 1.04 0.43 (0.42-0.44) 4.36 (4.23-4.49)
2007: 16 184 1.82 ± 0.94 0.45 (0.44-0.46) 3.98 (3.90-4.06)
male   3688 1.72 ± 0.90 0.45 (0.43-0.47) 3.78 (3.63-3.94)
female 12 532 1.86 ± 0.97 0.45 (0.44-0.46) 4.09 (3.99-4.19)
2008: 15 373 1.85 ± 0.91 0.49 (0.48-0.50) 3.94 (3.86-4.02)
male   3638 1.77 ± 0.85 0.51 (0.49-0.54) 3.73 (3.59-3.88)
female 11 669 1.86 ± 0.92 0.49 (0.48-0.50) 3.95 (3.86-4.05)
TAble 4. The z-scores for thyrotropin and free thyroxine through 2004-2008 between men and women
Analyte Year
Thyrotropin: 2004 2005 2006 2007 2008
critical 12.99038 20.25741 22.22752 24.66272 23.95856
calculated  5.126503  9.486049  7.275864  8.338785  5.889174
Free thyroxine: 2004 2005 2006 2007 2008
critical 13.86993 21.73103 23.50346 26.08807 25.3281
calculated 11.28558 20.61167 21.88634 21.44414 21.27315
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Reference intervals predict that approximately 95% of the 
values in the population will lie within the range given 
by lower and upper values; and of the remaining 5%, half 
the values will be higher and half will be lower than the 
limits of this range if the variable being measured has a 
normal distribution. Skewed distributions are also found 
for most of the analytes, but can often be mathematically 
transformed to a normal distribution. Data collected from a 
patient must be interpreted in comparison with reference 
data. Therefore, reference values and intervals are impor-
tant tools in providing a basis for interpreting laboratory 
results. However, to produce high quality reference values 
according to the recommendations of IFCC for all relevant 
analytes is far beyond the capacity of a single laboratory. 
The values for most analytes, including thyroid hormones, 
are to some degree population-, method-, and instrument-
dependent (9-14). For example, thyroid hormone values 
would be quite different between radioimmunoassay and 
chemiluminescence methods. Thus, one would find a se-
ries of thyroid reference data that have been published 
using different analytical methods and instruments, and 
choose one of them to use in a laboratory that best suits 
the situation. However, differences between populations 
are also an issue and can reduce the validity of reference 
values (15). Even the transfer of reference intervals is not 
an easy task for laboratories. A well-known method to de-
termine if one can use some other laboratories’ reference 
interval is to measure the analyte on 20 healthy people and 
compare these values with the provided 95% interval. If 3 
or more of the 20 values lie outside the interval, then one 
cannot transfer that reference interval. Additionally, gath-
ering and collecting sufficient numbers of samples from 
sub-populations, for example, pediatric groups or preg-
nant women, is not possible for a clinical laboratory that 
faces a typical load of daily routine work.
All these factors have forced clinical laboratories to use 
“somebody else’s” reference values, specifically those de-
rived from the equipment of reagent manufacturers, or 
values obtained from the literature. In either case, the ref-
erence range given on a laboratory report may actually be 
little more than a “good guess” for a normal population.
Various indirect methods have been developed for estab-
lishing reference intervals from the results of unselected 
hospital patients. One is the Bhattacharya method, which 
assumes the distribution to be Gaussian. The modified 
Bhattacharya method gives higher upper reference limits 
for most of the analytes examined (16). This method is also 
applied to internal quality control data and compared with 
the average of normals (AoN) method (17). Other math-
ematical formulas have also been proposed (18).
Reference intervals for TSH reported in different popula-
tions and different analyzers show significant differences 
in the lower and upper limits: lower limits ranged from 0.17 
to 0.6 and upper limits from 3.63 to 5.95 mU/L (9-13). These 
discrepancies arise because of the use of different analyz-
ers in different locations and also the methodology used 





calculated  5.173313  3.445187
2005-2006:
critical 30.05058 32.0599
calculated  3.908814 22.79545
2006-2007:
critical 33.17397 35.12424
calculated  6.068314 20.94026
2007-2008:
critical 34.4004 36.38286
calculated  2.390217  5.096467
TAble 6. Reference and confidence intervals for thyrotropin and free thyroxine calculated from patient data (indirect method). 
Indirect method direct method Manufacturer’s
Analyte n reference interval lRl (90% CI) uRl (90% CI) reference interval recommendations
Thyrotropin: 55 318  0.43-3.93 0.425-0.435 3.887-3.974
0.4-4.2  0.27-4.2male 11 779  0.43-3.77 0.424-0.445 3.636-3.806
female 43 539  0.43-4.04 0.429-0.439 3.987-4.083
Free thyroxine: 62 713 11.98-21.33 11.669-12.299 20.777-21.898
10.3-23.2 12.0-22.0male 13 395 12.66-22.23 11.940-13.423 20.966-23.571
female 49 318 11.91-20.98 11.573-12.257 20.386-21.591
* Transferred data according to International Federation of Clinical Chemistry recommendations that we use currently in our laboratory (direct 
method). and manufacturer’s recommended reference intervals. Abbreviations: lRl – lower reference limit; uRl – upper reference limit; CI – confi-
dence interval.
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to establish reference intervals. Ethnic differences should 
also be considered when establishing reference intervals 
(19,20).
From the clinical point of view, it is important to decide 
whether the patient has a subclinical thyroid condition, 
because this determines what to do when a patient is 
found to have mild abnormalities in TSH levels. Recent 
recommendations regarding subclinical hyperthyroidism 
suggest different advice on its management, depending 
on whether the TSH concentration is lower than 0.1 mIU/L 
or 0.1-0.4 mIU/L (21). This makes the lower reference limit 
as important as the upper reference limit for TSH. More-
over, there are published laboratory guidelines indicating 
that more than 95% of normal individuals have TSH levels 
below 2.5 mU/L (14). Establishing of a more precise and 
true reference interval for TSH has important implications 
for both screening and treatment of thyroid disease. Al-
though clinical data inform us that TSH values greater than 
2.5 mU/L are predictive of progression to overt hypothy-
roidism (22), there are also contradictory opinions claiming 
that no firm evidence is available that lowering the upper 
limit will provide any short- or long-term benefit for the 
patient. Additionally, this may increase the risk of thyroxine 
over-treatment, possibly resulting in subclinical hyperthy-
roidism (23). However, cut-off limits for diagnosis or con-
sidering treatment of subclinical thyroid dysfunction are a 
separate issue and should not be confused with the refer-
ence ranges. Such cut-offs may be lower than the upper 
limit of the reference interval (24). There are other studies 
calculating reference limits obtained in hospitalized pa-
tients for catalytic activity of serum enzymes (25) or for 
other clinical chemistry analytes (26).
Our overall limits for TSH were 0.43-3.93 (90% CI was 0.425-
0.435 and 3.887-3.974 for lower and upper limits, respec-
tively); our upper limit for TSH was slightly lower than the 
transferred and manufacturer’s values. While our lower refer-
ence limit agreed well with the transferred values, it was sig-
nificantly higher than the manufacturer’s limit. There were 
no differences between the years, showing that the meth-
od we used to estimate the reference intervals was robust 
and not affected by environmental factors during the years; 
the overall number of participants’ results in the study ex-
ceeded 50 000. Additionally, to avoid bad practices in the 
calculation of reference intervals, such as computing the in-
tervals without visual inspection of the data, stem-and-leaf 
plots and histograms were used, and they revealed heavily 
skewed data. Also, to avoid arbitrary truncation of data, an-
other common mistake, an outlier detection program was 
used until no outlier was left. Although there are some other 
algorithms for the detection of outliers in reference distribu-
tions, they still need reliable statistical evidence before being 
used (27). The reference interval for free T4 was 11.98-21.33 
pmol/L, with a 90% confidence interval of 11.67-12.30 for 
the lower, and 20.777-21.898 for the upper reference limits, 
calculated from more than 60 000 results. There was again 
no statistical difference by year or sex.
The confidence intervals are calculated for lower and up-
per limits for both analytes. Instead of estimating the pa-
rameter by a single value, an interval likely to include the 
parameter is given. Thus, confidence intervals are used to 
indicate the reliability of an estimate, and it shows how 
likely the interval is to contain the parameter.
In conclusion, establishing reference values from patients’ 
results has many advantages, including being the cheap-
est and easiest way to collect data. Because they are de-
rived from patients with the same conditions, they are likely 
to match clinical results better. There are also several argu-
ments against using a hospitalized population, including 
the idea that all the methods are “indirect” and not in ac-
cordance with the IFCC recommendations. Although little 
is known about the participants from whom the values are 
derived, and “normal” values may vary between hospitals, 
this is an advantage rather than a disadvantage because by 
using hospital data, the idea of developing reference values 
for each laboratory and hospital becomes possible. Final-
ly, the establishment of a more precise and true reference 
intervals for both analytes would give a better chance for 
diagnosis or considering treatment of thyroid dysfunction 
than using manufacturer’s values or transferred intervals.
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